The Trump administration gave a drug-making contract worth up to $812 million to a small Virginia firm that was founded less than 6 months ago

Published on:

The Trump administration has granted a $812 million contract to a small Virginia firm to boost US production of pharmaceuticals.  The firm, Phlow, was only founded in January, and describes itself as a “public benefit pharmaceutical manufacturing company.”  Its CEO, Dr Eric Edwards, told the Associated Press that Phlow’s mission is to make the US drug supply chain less reliant on other countries. According to Stat News, Edwards has a checkered history in the pharmaceutical industry. The Trump administration says Phlow’s mission has been made more urgent by the coronavirus pandemic. White House trade adviser Peter Navarro told

Read more    Source: businessinsider.com

Leave a Reply